Skip to content
Winfred
Sign up
Back to Investors
NB

NG Bio

Venture Capital
Follow

Portfolio

1

companies

By category

  • BioTech£1.4M

By location

  • York£1.4M

Portfolio companies

M

Mesenbio

Developing engineered stem-cell treatments for arthritis.

Team

Jason Goldstein

Jason Goldstein

Co-founder

Jason brings biotech investment and board experience from roles at NG Bio, Stealth Mode Biotech, and Mesenbio. He also holds an MBA from London Business School.

LinkedIn

Recent investments

£1.4M

Mesenbio raises £1.4m to advance arthritis therapies towards clinical trials.

BioTech

The funding round was co-led by DSW Ventures and NG Bio alongside a grant from Innovate UK.

"We have been developing this method of treatment for a decade now, with support from Versus Arthritis, and it has proved successful in laboratory tests, but the funding will allow us to move toward human clinical trials."
— Paul Genever, Professor
M
Mesenbio— York, UK Follow
DV
NB
Innovate UK
DSW Ventures + 2 others